Safety of the newer disease-modifying agents for multiple sclerosis: disproportionality analysis in the FDA Adverse Events Reporting System database.

by Vasiliki Nikolopoulou, Spyridon Siafis, Antonios Milonas, Dimitrios Kouvelas, Georgios Papazisis
Published 2019-06-01

Prevalence of Cannabis Use Among Medical Students: A Systematic Review and Meta-analysis

by Georgios Papazisis, Spyridon Siafis, Ioannis Tsakiridis, Ioannis Koulas, Themistoklis Dagklis, Dimitrios Kouvelas
Published 2018-10-01

The Administrative Prevalence of Multiple Sclerosis in Greece on the Basis of a Nationwide Prescription Database

by Christos Bakirtzis, Eleni Grigoriadou, Marina Kleopatra Boziki, Evangelia Kesidou, Spyridon Siafis, Spyridon Siafis, Theodoros Moysiadis, Dimitra Tsakona, Eleftherios Thireos, Ioannis Nikolaidis, Chrysa Pourzitaki, Dimitrios Kouvelas, Georgios Papazisis, Dimitrios Tsalikakis, Nikolaos Grigoriadis
Published 2020-09-01

Improved strategies to counter the COVID-19 pandemic: Lockdowns vs. primary and community healthcare

by Konstantinos Farsalinos, Konstantinos Poulas, Dimitrios Kouretas, Apostolos Vantarakis, Michalis Leotsinidis, Dimitrios Kouvelas, Anca Oana Docea, Ronald Kostoff, Grigorios T. Gerotziafas, Michael N. Antoniou, Riccardo Polosa, Anastastia Barbouni, Vassiliki Yiakoumaki, Theodoros V. Giannouchos, Pantelis G. Bagos, George Lazopoulos, Boris N. Izotov, Victor A. Tutelyan, Michael Aschner, Thomas Hartung, Heather M. Wallace, Félix Carvalho, Jose L. Domingo, Aristides Tsatsakis
Published 2021-01-01